Connect with us
European Gaming Congress 2024

Fintech PR

MedaWeek Barcelona 2023 concludes with a call for economic development in the Mediterranean amid uncertainty and conflicts



  • Successful turnout at MedaWeek Barcelona 2023, the Mediterranean Week of Economic Leaders from over 25 countries, held at the iconic Llotja de Mar building on November 15 and 16.
  • The 12 forums of the summit addressed major challenges in the Mediterranean, such as climate change, digitization, female entrepreneurship, sustainable transition, and business opportunities in Islamic finance, health, textile industry, and tourism.
  • The Association of Chambers of Commerce and Industry of the Mediterranean (ASCAME) announces plans to establish a regional council for climate change in the Mediterranean, a multilateral agreement involving various institutions to address the regional gap in digital transformation, the organization of an Economic Leaders Summit for the three continents in Egypt in 2024, and a partnership with the General Council for Islamic Banks to promote funds for climate financing and sustainability in the region.

BARCELONA, Spain, Nov. 20, 2023 /PRNewswire/ — A total of 1,200 people attended in person, and another 500 joined via streaming, all from over 25 countries spanning the Mediterranean region, Europe, and Africa, participated in the 17th edition of MedaWeek, the Mediterranean Week of Economic Leaders, held at the Llotja de Mar in Barcelona on November 15 and 16. This event, organized by the Association of Chambers of Commerce and Industry of the Mediterranean (ASCAME) in collaboration with the Chamber of Commerce of Barcelona, is the key socio-economic summit in the Mediterranean. Despite the current geopolitical crisis in the region, it successfully mobilized and brought together major Mediterranean institutions.



Throughout the two days of MedaWeek Barcelona 2023, in the 12 forums held, leaders of these institutions, along with entrepreneurs from various sectors and international experts, discussed and provided solutions to current challenges in the Mediterranean. These challenges include climate change, digital connectivity in the countries of the region, female entrepreneurship, sustainable transition, and business opportunities in sectors such as Islamic finance, health, and tourism.

All participants agreed that “these challenges will not be successfully addressed unless we find peace through diplomatic means in our region.” As explained by Anwar Zibaoui, the general coordinator of ASCAME, “it has been a great challenge to hold MedaWeek when there is war and violence in some countries of the region.” In his opinion, “the significant participation we have had from the regional private sector is a commitment to the development and building bridges of understanding and peace in the region.” Ahmed El Wakil, president of ASCAME, took advantage of this gathering of Mediterranean economic leaders in Barcelona to call for “more protectionism and collaboration, and to strengthen multilateralism and alliances.”

ASCAME’s New Agreements to Enhance Mediterranean Competitiveness


During MedaWeek Barcelona 2023, ASCAME has announced several initiatives that will impact the prosperity and sustainable development of the region. Firstly, there will be the establishment of a regional council for climate change in the Mediterranean, aimed at activating private sector involvement and collaboration with governments and civil society in this collective fight that encompasses the entire region.

Secondly, ASCAME takes a significant step forward to address the digital gap among Mediterranean businesses. As highlighted in several sessions of MedaWeek Barcelona 2023, increased digital connectivity among Mediterranean countries would contribute to higher rates of female entrepreneurship, improved employment rates in developing countries, and facilitate the necessary sustainable transition, including the incorporation of green technologies in all productive sectors. During these sessions, for example, Digital Realty, the largest provider of Cloud and Data Center Carrier Neutral, presented its project for digital interconnection among all Mediterranean countries through submarine cables. By 2027, Digital Realty plans to increase the capacity of submarine cabling for data transfer in the Mediterranean tenfold.

ASCAME has announced the organization of an Economic Leaders Summit for the three continents – Africa, Europe, and the Middle East – to be held in Egypt in May 2024. It will be a new opportunity to discuss and find common solutions to challenges such as the impact of the geopolitical context on the Mediterranean economy, the latest technological trends transforming industries and sectors, and the new globally projected corridors that will make the Mediterranean a key hub.

Lastly, ASCAME has made public its agreement with the General Council of Islamic Banks worldwide to collaborate in promoting initiatives supporting climate financing and the promotion of projects fostering sustainable development in the region.

About ASCAME: The Association of Chambers of Commerce and Industry of the Mediterranean (ASCAME) is a non-profit international organization representing the private sector in the Mediterranean. It brings together Chambers of Commerce and Industry and similar entities from 23 countries on both shores of the region and advocating for the interests of private sector and millions of businesses.


For more information:
Susana García
Tel.: +34910 001 948
[email protected]






Cision View original content:

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024




STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting


The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision


The following files are available for download:

Invitation to presentation of EQT AB’s Q1 Announcement 2024,c3285895


EQT AB Group


View original content:

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs



  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”


Photo –

Cision View original content to download multimedia:

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update




VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.


BioVaxys Technology Corp. (, a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit and connect with us on X and LinkedIn.


Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo –

Cision View original content:

Continue Reading